LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS is named as the registrant in 22 lobbying reports we hold for 2026-Q2, for 22 clients. 0 reports of 22 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| ALKERMES, INC. | 2026-Q2: $60,000 in income | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | 2026-Q2: $50,000 in income | 1 |
| ARDELYX, INC. | 2026-Q2: $30,000 in income | 1 |
| AVADEL PHARMACEUTICALS, PLC | 2026-Q2: $60,000 in income | 1 |
| BICYCLE THERAPEUTICS | 2026-Q2: $150,000 in income | 1 |
| ERISA INDUSTRY COMMITTEE (ERIC) | 2026-Q2: $30,000 in income | 1 |
| GLAXOSMITHKLINE LLC | 2026-Q2: $50,000 in income | 1 |
| HARMONY BIOSCIENCES | 2026-Q2: $50,000 in income | 1 |
| INCYTE CORPORATION | 2026-Q2: $50,000 in income | 1 |
| INSMED INCORPORATED | 2026-Q2: $20,000 in income | 1 |
| IONIS PHARMACEUTICALS, INC. | 2026-Q2: $30,000 in income | 1 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 2026-Q2: $20,000 in income | 1 |
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | 2026-Q2: $230,000 in income | 1 |
| NATERA, INC. | 2026-Q2: $20,000 in income | 1 |
| NEUROPACE, INC. | 2026-Q2: $30,000 in income | 1 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $30,000 in income | 1 |
| PTC THERAPEUTICS, INC. | 2026-Q2: $50,000 in income | 1 |
| REGENXBIO INC. | 2026-Q2: $60,000 in income | 1 |
| REZOLUTE, INC. | 2026-Q2: $40,000 in income | 1 |
| SAVARA INC. | 2026-Q2: $60,000 in income | 1 |
| STEALTH BIOTHERAPEUTICS INC. | 2026-Q2: $60,000 in income | 1 |
| UNIVERSITY OF LOUISVILLE HEALTH | 2026-Q2: $20,000 in income | 1 |
Lobbyists named in these reports
- ALANNA TEMME · 22 reports · earlier government job reported
- AMY CHEVALIER EFANTIS · 1 report · earlier government job reported
- MAXIMILIAN WALTER · 6 reports
- SONIA GOH · 9 reports
- SOPHIE KHANAHMADI · 12 reports · earlier government job reported
Bills named, and how the House and the Senate voted
13 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1262Mikaela Naylon Give Kids a Chance Act | Passed the House | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 1691Employee Business Expense Deduction Reinstatement Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 2213Medical Supply Chain Resiliency Act | Introduced | No recorded vote in our record |
| H.R. 4692MAMDANI Act | Introduced | No recorded vote in our record |
| H.R. 5269RESULTS Act | Introduced | No recorded vote in our record |
| S. 574Healthy Poultry Assistance and Indemnification Act of 2025 | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 932Give Kids a Chance Act of 2025 | Introduced | No recorded vote in our record |
| S. 1862ORPHAN Cures Act | Introduced | No recorded vote in our record |
| S. 2355Patients Deserve Price Tags Act | Reported by committee | No recorded vote in our record |
Issues named: Health Issues (13), Pharmacy (10), Medicare/Medicaid (7), Trade (domestic/foreign) (2).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| INSMED INCORPORATEDTrade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| REZOLUTE, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| UNIVERSITY OF LOUISVILLE HEALTHMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| STEALTH BIOTHERAPEUTICS INC.Health Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| SAVARA INC.Health Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| REGENXBIO INC.Health Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| PTC THERAPEUTICS, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPharmacy, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| NEUROPACE, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| NATERA, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)Pharmacy, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATIONHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| IONIS PHARMACEUTICALS, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| INCYTE CORPORATIONHealth Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| HARMONY BIOSCIENCESHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GLAXOSMITHKLINE LLCHealth Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| ERISA INDUSTRY COMMITTEE (ERIC)Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| BICYCLE THERAPEUTICSHealth Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| AVADEL PHARMACEUTICALS, PLCPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| ARDELYX, INC.Health Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| ALNYLAM PHARMACEUTICALS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ALKERMES, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.